Liu, J., Wei, L., Li, J., Liu, S., Wang, B., Cheng, J., Xie, Y., Xu, J., Yuan, R., Zhang, Z. (2026). Iparomlimab and tuvonralimab (PD-1/CTLA-4 bifunctional antibody) monotherapy or combination therapy in patients with advanced solid tumors treated.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23358